News | November 10, 2025
Zydus Lifesciences posts Q2 FY26 PAT at Rs. 1,258.6 Cr
Organic capex during the quarter amounted to Rs. 491.1 crore, supporting ongoing business expansion initiatives
Organic capex during the quarter amounted to Rs. 491.1 crore, supporting ongoing business expansion initiatives
Launched in Thailand, the ASEAN hub, marking an early entry into the fast-growing combination therapy market (DPP-4 and SGLT-2 inhibitor combination) with strong potential for market leadership
Gelhaus has a proven track record of driving business growth
Sumitomo Chemical began its nucleic acid drug substance contract manufacturing business in 2013
Revenue from operations registered a growth of 12% Y-o-Y at Rs 337.63 crores for H1 FY25
The company will set-up a pharmaceuticals formulation manufacturing unit with an investment of Rs. 100 crore in Odisha
Q2 FY23 business performance has been slow primarily due to lower volume offtake from pharmaceutical manufacturers
Blanda will be responsible for overseeing Evonik’s amino acids and functional feed additives business and the expansion of its precision livestock farming approach
MedTel aims to raise series A for rapid business expansion, product improvement & conducting relevant clinical validation studies.
This expansion announcement came right after raising series B funding of $27 Mn in a round led by Fundamentum Partnership, earlier this month.
Subscribe To Our Newsletter & Stay Updated
